Report Buyer, the online destination for business intelligence for major industry sectors, has added a new market report
The report “Who's Developing What in Drug Delivery 2009” available at http://www.reportbuyer.com/
The importance of drug delivery technology grows ever more acute and commercial and industry interest is continuing to build. The benefits to patients can be seen in improved medical outcomes, while the pharmaceutical industry is able to extend patent protection through novel delivery regimes, and bring new therapies to the market that would, previously, have been impossible to administer.
Consequently, the drug delivery sector has evolved from being simply a part of the pharmaceutical production process to a driving force for innovation and profits. As a result, developers of drug delivery products and technology have benefited from significant attention from customers and investors alike, and merger and acquisition activity is notable.
According to the report, many drug delivery development companies have been hit hard by the recession. With investor capital in short supply to fund technology developments, many smaller companies have failed. Positively, there have been signs on the horizon that investors are returning to the sector, but investment is more focused on innovative technologies that have a good chance of achieving commercial returns.
While pharmaceutical sales have risen steadily over the last five years, generating over US$720 billion in 2008, analysts are forecasting sales growth will slow over the next five years due to an unprecedented level of patent expiration compounded by the downturn in the global economy. At the same time, the global drug delivery market has tripled in value from an estimated US$26 billion in 2000.
The report “Who's Developing What in Drug Delivery 2009” is available from Report Buyer at:
http://www.reportbuyer.com/
Report Buyer product ID: ESP00452
About Report Buyer.
Report Buyer
(http://www.reportbuyer.com/
